-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of the cost of borrowed funds accounted for as interest expense.
-
Summary
-
X4 Pharmaceuticals, Inc quarterly/annual Interest Expense history and growth rate from 2016 to 2023.
- X4 Pharmaceuticals, Inc Interest Expense for the quarter ending June 30, 2024 was $2.18M, a 89.5% increase year-over-year.
- X4 Pharmaceuticals, Inc Interest Expense for the twelve months ending June 30, 2024 was $7.57M, a 71.3% increase year-over-year.
- X4 Pharmaceuticals, Inc annual Interest Expense for 2023 was $5.78M, a 44.7% increase from 2022.
- X4 Pharmaceuticals, Inc annual Interest Expense for 2022 was $3.99M, a 9.64% increase from 2021.
- X4 Pharmaceuticals, Inc annual Interest Expense for 2021 was $3.64M, a 35.5% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)